source name	characteristics[organism]	characteristics[organism part]	characteristics[disease]	characteristics[cell type]	characteristics[cell line]	characteristics[biological replicate]	characteristics[age]	characteristics[sex]	characteristics[compound]	assay name	technology type	comment[label]	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[cleavage agent details]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[proteomics data acquisition method]	comment[m/z acquisition range]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[cell line]	factor value[compound]
PXD032263-Sample-1	Homo sapiens	Pancreas	Adenocarcinoma	epithelial	BxPC-3	1	61Y	female	Control	run 1	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	HF01_20211208_YWT_KR_DIA_B1_F1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/05/PXD032263/HF01_20211208_YWT_KR_DIA_B1_F1_R1.raw	1	1	NT=Trypsin;AC=MS:1001251	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	400m/z-1200m/z	5 ppm	20 ppm	BxPC-3	Control
PXD032263-Sample-1	Homo sapiens	Pancreas	Adenocarcinoma	epithelial	BxPC-3	1	61Y	female	Control	run 2	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	HF01_20211208_YWT_KR_DIA_B2_F1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/05/PXD032263/HF01_20211208_YWT_KR_DIA_B2_F1_R1.raw	2	1	NT=Trypsin;AC=MS:1001251	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	400m/z-1200m/z	5 ppm	20 ppm	BxPC-3	Control
PXD032263-Sample-2	Homo sapiens	Pancreas	Adenocarcinoma	epithelial	BxPC-3	1	61Y	female	GEM	run 3	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	HF01_20211208_YWT_KR_DIA_B3_F1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/05/PXD032263/HF01_20211208_YWT_KR_DIA_B3_F1_R1.raw	1	1	NT=Trypsin;AC=MS:1001251	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	400m/z-1200m/z	5 ppm	20 ppm	BxPC-3	GEM
PXD032263-Sample-2	Homo sapiens	Pancreas	Adenocarcinoma	epithelial	BxPC-3	1	61Y	female	GEM	run 4	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	HF01_20211208_YWT_KR_DIA_B4_F1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/05/PXD032263/HF01_20211208_YWT_KR_DIA_B4_F1_R1.raw	2	1	NT=Trypsin;AC=MS:1001251	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	400m/z-1200m/z	5 ppm	20 ppm	BxPC-3	GEM
PXD032263-Sample-3	Homo sapiens	Pancreas	Epithelioid Carcinoma	epithelial	PANC-1	1	56Y	male	Control	run 5	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	HF01_20211208_YWT_KR_DIA_P1_F1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/05/PXD032263/HF01_20211208_YWT_KR_DIA_P1_F1_R1.raw	1	1	NT=Trypsin;AC=MS:1001251	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	400m/z-1200m/z	5 ppm	20 ppm	PANC-1	Control
PXD032263-Sample-3	Homo sapiens	Pancreas	Epithelioid Carcinoma	epithelial	PANC-1	1	56Y	male	Control	run 6	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	HF01_20211208_YWT_KR_DIA_P2_F1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/05/PXD032263/HF01_20211208_YWT_KR_DIA_P2_F1_R1.raw	2	1	NT=Trypsin;AC=MS:1001251	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	400m/z-1200m/z	5 ppm	20 ppm	PANC-1	Control
PXD032263-Sample-4	Homo sapiens	Pancreas	Epithelioid Carcinoma	epithelial	PANC-1	1	56Y	male	GEM	run 7	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	HF01_20211208_YWT_KR_DIA_P3_F1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/05/PXD032263/HF01_20211208_YWT_KR_DIA_P3_F1_R1.raw	1	1	NT=Trypsin;AC=MS:1001251	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	400m/z-1200m/z	5 ppm	20 ppm	PANC-1	GEM
PXD032263-Sample-4	Homo sapiens	Pancreas	Epithelioid Carcinoma	epithelial	PANC-1	1	56Y	male	GEM	run 8	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	HF01_20211208_YWT_KR_DIA_P4_F1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/05/PXD032263/HF01_20211208_YWT_KR_DIA_P4_F1_R1.raw	2	1	NT=Trypsin;AC=MS:1001251	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	400m/z-1200m/z	5 ppm	20 ppm	PANC-1	GEM
